Here, we propose that the cure rates for this malignancy might be improved by targeting MMP-2-mediated SDF-1/CXCR4 expression and pathway, thereby preventing reconstitution of tumor vasculature following radiation. The gene discussed is CXCR4; the disease is neoplasm.